Mark J. Ratain to Thymidine
This is a "connection" page, showing publications Mark J. Ratain has written about Thymidine.
Connection Strength
0.070
-
Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum(II) in patients with advanced cancer. Cancer Res. 1986 Aug; 46(8):4184-8.
Score: 0.070